Literature DB >> 6182174

Disturbances of selected plasma proteins in hyperdynamic septic shock.

J Witte, M Jochum, R Scherer, W Schramm, K Hochstrasser, H Fritz.   

Abstract

This study was performed on patients (n = 18) suffering from strictly defined hyperdynamic septic shock. Plasma factors (C-reactive protein, acid alpha 1-glycoprotein, fibrinogen, fibrinopeptide A, fibrinogen-fibrin split products, factor XIII, antithrombin III, complement factors C3 and C4, inter-alpha-trypsin-inhibitor and alpha 2-macroglobulin) measured during hyperdynamic septic shock were highly abnormal. The activation and consumption of clotting, fibrinolytic and complement factors due to system-specific proteinases (such as thrombokinase or plasminogen activators) seemed to be intensified by the nonspecific proteolytic activity of granulocytic proteinases probably released by the action of endotoxins. Possible therapeutic measures to maintain the endogeneous defence mechanism against enhanced proteolysis during septic shock are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6182174     DOI: 10.1007/bf01694524

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  18 in total

1.  [About degradation products of the inter-alpha-trypsin inhibitor in serum. I. The inter-alpha-trypsin inhibitor as precursor of the acid stable trypsin-plasmin-inhibitor of the serum (author's transl)].

Authors:  K Hochstrasser; J Niebel; H Feuth; K Lempart
Journal:  Klin Wochenschr       Date:  1977-04-01

2.  Endotoxin induced disseminated intravascular clotting: evidence that it is mediated by neutrophil production of tissue factor.

Authors:  R G Lerner; R Goldstein; G Cummings
Journal:  Thromb Res       Date:  1977-08       Impact factor: 3.944

3.  The occurrence and significance of fibrin-fibrinogen degradation products (FDP) in acute infections.

Authors:  P Skånsberg; S Cronberg; I M Nilsson
Journal:  Scand J Infect Dis       Date:  1974

4.  Factor XIII.

Authors:  M S Losowsky; K J Miloszewski
Journal:  Br J Haematol       Date:  1977-09       Impact factor: 6.998

5.  [Radioimmunoassay of fibrinopeptide A: double antibody method].

Authors:  W Schramm; M Schmid; F W Erhardt
Journal:  Fortschr Med       Date:  1977-05-19

6.  Endothelium and shock.

Authors:  N Freudenberg
Journal:  Pathol Res Pract       Date:  1978-05       Impact factor: 3.250

7.  Evaluation of hypercoagulability in septic abortion.

Authors:  H Graeff; E Ernst; J A Bocaz; R von Hugo; R Hafter
Journal:  Haemostasis       Date:  1976

8.  Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects.

Authors:  R Egbring; W Schmidt; G Fuchs; K Havemann
Journal:  Blood       Date:  1977-02       Impact factor: 22.113

9.  Complement activation during subsequent stages of canine endotoxin shock.

Authors:  A O Aasen; O J Mellbye; K Ohlsson
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

10.  Effect of human granulocytic elastase on isolated human antithrombin III.

Authors:  M Jochum; S Lander; N Heimburger; H Fritz
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1981-02
View more
  7 in total

1.  Hepatic dysfunction during bacterial sepsis.

Authors:  A E Gimson
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 2.  Prevalence, pathophysiological mechanisms and factors affecting urolithiasis.

Authors:  Aslam Khan
Journal:  Int Urol Nephrol       Date:  2018-03-22       Impact factor: 2.370

3.  Immunoreactive trypsin in the adult respiratory distress syndrome.

Authors:  G Deby-Dupont; M Haas; J Pincemail; M Braun; M Lamy; C Deby; P Franchimont
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

Review 4.  Plasma fibronectin: relevance for anesthesiology and intensive care.

Authors:  J E Doran; P Lundsgaard-Hansen; E Rubli
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

5.  Purified fibronectin administration to patients with severe abdominal infections. A controlled clinical trial.

Authors:  P Lundsgaard-Hansen; J E Doran; E Rubli; E Papp; J J Morgenthaler; P Späth
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

6.  Glycosylation pattern of human inter-alpha-inhibitor heavy chains.

Authors:  C Flahaut; C Capon; M Balduyck; G Ricart; P Sautiere; J Mizon
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

7.  Effects of coagulation factor XIII on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation in experimental endotoxemia.

Authors:  Jürgen Birnbaum; Ortrud Vargas Hein; Carsten Lührs; Oskar Rückbeil; Claudia Spies; Sabine Ziemer; Matthias Gründling; Taras Usichenko; Konrad Meissner; Dragan Pavlovic; Wolfgang J Kox; Christian Lehmann
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.